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Abstract  
Aim: The aim of this study was to analyze relative citation ratio (RCR) of top twenty 
Macedonian biomedical scientists with a new metric that uses citation rates to measure 
influence at the article level. 
Material and Methods: Top twenty Macedonian biomedical scientists were identified by 
GoPubMed on the base of the number of deposited abstracts in PubMed, corrected with the 
data from previously published paper, and completed with the Macedonian biomedical scientists 
working in countries outside the Republic of Macedonia, but born or previously worked in the 
country. iCite was used as a tool to access a dashboard of bibliometrics for papers associated 
with a portfolio. 
Results: The biggest number of top twenty Macedonian biomedical scientists has RCR lower 
than one. Only four Macedonian biomedical scientists have bigger RCR in comparison with 
those in PubMed. The most prominent RCR of 2.29 has Rosoklija G. RCR of the most 
influenced individual papers deposited in PubMed has shown the biggest value for the paper of 
Efremov D (35.19). This paper has the biggest number of authors (860). 
Conclusion: It is necessary to accept top twenty Macedonian biomedical scientists as an 
example of new metric that uses citation rates to measure influence at the article level, rather 
than qualification of the best Macedonian biomedical scientists. 
 
 
 
  
Introduction 
  
The impact factor (IF) of an academic journal 
is a measure reflecting the average number of 
citations to recent articles published in that journal. It 
is mostly used as a measure of the relative 
importance of a journal within its field, with journals 
with higher impact factors meaning to be more 
important than those with lower ones. The impact 
factor was devised by Eugene Garfield, the founder of 
the Institute for Scientific Information [1]. Impact 
factors are calculated yearly starting from 1975 for 
those journals that are indexed in the Journal Citation 
Reports [2]. Several other indexes were introduced for 
measuring the citation metrics.  
Citation metrics must be article-level, field-
normalized in a way that is scalable from small to 
large portfolios without introducing significant bias at 
any level, benchmarked to peer performance in order 
to be interpretable, and correlated with expert opinion. 
In addition, metrics should be freely accessible and 
calculated in a transparent way [1]. Many efforts have 
been made to fulfil one or more of these requirements, 
including citation normalization to journals or journal 
categories [3-8], citation percentiles [8, 9], eigenvector 
normalization [9, 10] or source-normalization [11, 12] 
including the Mean Normalized Citation Score [7] and 
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Source-Normalized Impact per Paper metrics [12]. 
While all are improvements on Impact Factor, none 
meets all of the criteria listed above.  
a)
 
b)
 
c)
 
d)
 
e) 
 
Figure 1: Several steps should be followed in order to calculate 
relative citation ratio of top twenty Macedonian biomedical scientists 
with a new metric that uses citation rates to measure influence at 
the article level 
 
 Furthermore, these existing approaches are 
often unhelpful to decision-makers because they 
aggregate works from researchers across disparate 
geographical regions and institutional types. For 
example, current methods do not provide a way for 
primarily undergraduate institutions to compare their 
portfolios against other teaching-focused institutions, 
nor do they allow developing nations to compare their 
research to that done in other developing nations [13]. 
Incorporating a customizable benchmark as an 
integral part of an ideal citation metric would enable 
such an apples to apple comparison and facilitate 
downstream decision-making activity. 
We report here the development and 
validation of the Relative Citation Ratio (RCR) metric, 
which meets all of the above criteria and is based on 
the novel idea of using the co-citation network of each 
article to field- and time-normalize by calculating the 
expected citation rate from the aggregate citation 
behavior of a topically linked cohort. An average 
citation rate is computed for the network, 
benchmarked to peer performance, and used as the 
RCR denominator; as is true of other bibliometrics, 
article citation rate (ACR) is used as the numerator. 
We use the RCR metric here to determine the extent 
to which National Institutes of Health (NIH) awardees 
maintain high or low levels of influence on their 
respective fields of research. 
 The aim of this study was to analyze relative 
citation ratio (RCR) of top twenty Macedonian 
biomedical scientists with a new metric that uses 
citation rates to measure influence at the article level. 
 
 
Material and Methods 
  
Top twenty Macedonian biomedical scientists 
were identified by GoPubMed on the base of the 
number of deposited abstracts in PubMed [14], 
corrected with the data from previously published 
paper [15], and completed with the Macedonian 
biomedical scientists working in countries outside the 
Republic of Macedonia, but born or previously worked 
in the country (Table 1).   
iCite was used as a tool to access a 
dashboard of bibliometrics for papers associated with 
a portfolio. iCite is a powerful web application that 
provides a panel of bibliometric information for journal 
publications within a defined analysis group (where an 
analysis group can consist of a single article or a very 
large group of articles). The data produced by iCite 
can be downloaded as a customized report from the 
dashboard and could be used to understand the 
influence of articles within an analysis group. An 
example application for iCite might be to compare how 
the influence of a portfolio of articles compares to the 
remaining articles that come out of grants funded by 
the NIH [2]. 
 
Spiroski. Relative Citation Ratio of Top Twenty Macedonian Biomedical Scientists in PubMed 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2016 Jun 15; 4(2):187-193.                                                                                                                                                         189 
 
Table 1: Number of abstracts deposited in PubMed, total 
number of PubMed abstracts in citation base, and publications 
per year of top twenty Macedonian biomedical scientists 
(November 17, 2015) 
Rank 
Macedonian Biomedical Scientist (November 
17, 2015) 
Pubs 
Abstracts 
Total Pubs 
in Citation 
base 
Pubs/Year 
1 "Polenakovic M" OR "Polenakovik M"
&
 189 108 5.68 
2 "Efremov G"
&
 156 48 2.67 
3 "Tasic V" 123 78 4.33 
4 "Spasovski G" 115 79 4.16 
5 "Efremov D"
&1
 113 81 4.26 
6 "Gucev Z" OR "Guchev Z" 85 51 2.68 
7 "Gogusev J"
2
 78 37 1.95 
8 "Kocova M" OR "Kochova M" 76 51 2.68 
9 "Bosevski M" 73 49 5.44 
10 "Sikole A" 67 51 2.83 
11 "Petrusevska G" OR "Petrushevska G" 67 46 2.56 
12 "Stafilov T" 63 45 2.50 
13 "Grcevska L" OR "Grchevska L" 63 42 2.33 
14 "Popov Z"
&
 62 45 2.37 
15 "Dimovski A"
&
 62 21 1.17 
16 "Ivanovski N" 58 46 2.56 
17 "Spiroski M" OR "Spirovski M" 52 35 2.69 
18 "Tofovic S"
3
 50 46 2.56 
19 "Rosoklija G"
&4
 48 35 1.84 
20 "Pop-Jordanova N" OR "Pop Jordanova N"
&
 47 27 1.93 
&, member of Macedonian Academy of Science and Arts; 
1
, Molecular Hematology Unit, 
International Centre for Genetic Engineering and Biotechnology, Rome, Italy;  
2
, Inserm 
U507 and U1016, Institut Cochin, 75014 Paris, France; 
3
, Department of Pharmacology 
and Chemical Biology, University of Pittsburgh, School of Medicine, PA, USA; 
4
,  
Department of Psychiatry, Columbia University, New York, USA. 
 
The following data are produced using iCite: 
total number of articles within the analysis group 
(Total Pubs); mean number of articles published per 
year (Pubs/Year); number of citations for articles in 
the analysis group per year (Cites/Year): maximum, 
mean, standard error of the mean, and median; 
Relative Citation Ratio (RCR): maximum, mean, 
standard error of the mean, and median; and 
Weighted RCR: the sum of the RCRs for the articles 
within the analysis group. 
The Relative Citation Ratio is a new metric 
developed within the Office of Portfolio Analysis 
(OPA) that represents a citation-based measure of the 
scientific influence of one or more articles. It is 
calculated as the cites/year of each paper, normalized 
to the citations per year received by NIH-funded 
papers in the same field and year. A paper with an 
RCR of 1.0 has received the same number of 
cites/year as the median NIH-funded paper in its field, 
while a paper with an RCR of 2.0 has received twice 
as many cites/year as the median NIH-funded paper 
in its field. The displayed values are the average and 
standard deviation of the papers in the group along 
with the median. 
For each of the top twenty Macedonian 
biomedical scientists, PubMed was searched (on 
November 17, 2015) and the results were formatted 
as PMID list (Figure 1a). The PMID list was copied 
(Figure 1b) and transferred to iCite Beta [2] in the New 
Analysis window (Figure 1c). Individual results of top 
twenty Macedonian biomedical scientists were shown 
and captured for further analyses (Figure 1d).  The 
citation rates to measure influence at the article level 
for each top twenty Macedonian biomedical scientists 
were shown and captured for further analysis (Figure 
1e). 
 
Results 
 
 Percent of cited papers in citation base of 
deposited abstracts in PubMed from top twenty 
Macedonian biomedical scientists (November 17, 
2015) is shown in Fig. 1.  
It can be seen that two authors (Efremov G 
and Dimovski A) have the lowest percent of cited 
papers (30.77% and 33.87%, respectively). Most of 
the authors have a percent of cited papers between 
35% and 80%, and only one author has 92% of cited 
papers (Tofovic S). 
 
 
Figure 1: Percent of cited papers in citation base of deposited 
abstracts in PubMed from top twenty Macedonian biomedical 
scientists (November 17, 2015) 
 
 Cites per year of deposited abstracts in 
PubMed from top twenty Macedonian biomedical 
scientists (November 17, 2015) are shown in Fig. 2.  
It can be seen that cites per year are very 
heterogeneous finding between top twenty 
Macedonian biomedical scientists. The smallest 
number of cites per year was noticed by Grcevska L 
OR Grchevska L (0.2 cites per year). Most of the top 
twenty Macedonian biomedical scientists were cited 
between 0.2 and 2.0 per year.  
Two scientists were cited between 2.0 and 4.0 
times per year (Spasovski G and Kocova M OR 
Kochova M). Only two of Macedonian top twenty 
biomedical scientists were cited between 6 and 8 
times per year (Efremov D and Rosoklija G). 
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Figure 2: Cites per year of deposited abstracts in PubMed from top 
twenty Macedonian biomedical scientists (November 17, 2015) 
 
 Relative citation ratio (RCR) of deposited 
abstracts in PubMed from top twenty Macedonian 
biomedical scientists (November 17, 2015) is shown 
in Fig. 3.  
 The lowest Relative citation ratio (RCR) was 
calculated for Grcevska L OR Grchevska L (0.12). 
The biggest number of top twenty Macedonian 
biomedical scientists have Relative citation ratio lower 
than one, which means lower citation than calculated 
citation in PubMed for the given subject. 
 Only four Macedonian biomedical scientists 
have bigger Relative citation ratio in comparison with 
those in PubMed. Spasovski G and Efremov D have 
Relative citation ratio of 1.34 and 1.41, respectively. 
Kocova M OR Kochova M has Relative citation ratio of 
1.55, and the most prominent Relative citation ratio of 
2.29 has Rosoklija G, a member of Macedonian 
Academy of Science and Arts, and affiliated with 
Department of Psychiatry, Columbia University, New 
York, USA. 
 
Figure 3: Relative citation ratio (RCR) of deposited abstracts in 
PubMed from top twenty Macedonian biomedical scientists 
(November 17, 2015) 
 
In the Fig. 4 we can see the weighted relative 
citation ratio of deposited abstracts in PubMed from 
top twenty Macedonian biomedical scientists 
(November 17, 2015).  
 The smallest number of Weighted Relative 
Citation Ratio was calculated for Grcevska L OR 
Grchevska L (5.11) and for Pop-Jordanova N OR Pop 
Jordanova N (6.28). The majority of top twenty 
Macedonian biomedical scientists belong to the group 
with Weighted Relative Citation Ratio bellow 60, and 
the rest four scientists were positioned between 60 
and 120. The biggest Weighted Relative Citation Ratio 
was calculated for Spasovski G and Efremov D with 
106.21 and 114.54, respectively. 
 
Figure 4: Weighted relative citation ratio of deposited abstracts in 
PubMed from top twenty Macedonian biomedical scientists 
(November 17, 2015) 
 
 A number of total citations, citations per year, 
expected citations per year, field citations rate, relative 
citation ratio, and the number of authors of the most 
influenced individual papers deposited in PubMed by 
top twenty Macedonian biomedical scientists 
(November 17, 2015) is shown in Table 2. 
 The number of total citations of the most 
influenced individual papers deposited in PubMed by 
top twenty Macedonian biomedical scientists is very 
heterogeneous and varies between 5 (Sikole A) and  
403 (Efremov D). The most cited individual papers are 
from Efremov D, Gucev Z OR Guchev Z, and 
Gogusev J with 403, 308, and 290 citations 
respectively. The biggest citation per year was noted 
in the paper of Efremov G with 201.49 citations [20], 
followed by the paper of Rosoklija G with 41.60 
citations per year [34], and the paper from Spasovski 
G with 36.50 citations per year [19]. The smallest 
number of citations per year was found for the paper 
of Pop-Jordanova N OR Pop Jordanova N with 2.67 
citations per year [35] (Table 2). 
 Expected Citations per Year and Field 
Citation Rate are calculated values by iCite for the 
corresponding field of the author. They are very 
heterogeneous and vary two or three times between 
them. Obviously, they influence on the final results of 
the calculated values for each of top twenty 
Macedonian biomedical authors (Table 2). 
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Table 2: Number of total citations, citations per year, expected citations per year, field citations rate, relative citation ratio, and 
number of authors of the most influenced individual papers deposited in PubMed by top twenty Macedonian biomedical scientists 
(November 17, 2015) 
Macedonian Biomedical Scientist 
(November 17, 2015) 
PubMed ID 
 
Total 
Citations 
Citations per 
Year 
Expected 
Citations per 
Year 
Field Citation 
Rate 
Relative 
Citation Ratio 
Number of 
authors 
Year Reference 
"Polenakovic M" OR "Polenakovik M" 16391464 50 6.25 1.96 3.42 3.18 4 2006 [16] 
"Efremov G" 17351267 68 9.71 3.67 6.74 2.64 24 2007 [17] 
"Tasic V" 15627218 112 12.44 4.38 8.72 2.84 12 2005 [18] 
"Spasovski G" 22626821 73 36.50 2.71 4.57 13.48 24 2012 [19] 
"Efremov D" 22077192 403 201.49 5.73 9.66 35.19 860 2012 [20] 
"Gucev Z" OR "Guchev Z" 8673727 308 17.11 1.74 5.58 9.81 9 1996 [21] 
"Gogusev J" 8995751 290 17.06 1.84 5.39 9.29 7 1997 [22] 
"Kocova M" OR "Kochova M" 22638547 56 28.00 3.50 5.90 8.01 25 2012 [23] 
"Bosevski M" 21885395 14 7.00 3.55 6.00 1.97 125 2012 [24] 
"Sikole A" 23635017 5 5.00 1.89 3.08 2.64 9 2013 [25] 
"Petrusevska G" OR "Petrushevska G" 8807589 133 7.39 1.86 5.96 3.97 8 1996 [26] 
"Stafilov T" 19944530 23 5.75 1.25 1.89 4.60 6 2010 [27] 
"Grcevska L" OR "Grchevska L" 10196005 29 1.93 1.64 3.96 1.18 2 1999 [28] 
"Popov Z" 20626425 15 5.00 2.82 4.75 1.77 7 2011 [29] 
"Dimovski A" 16413012 61 7.62 2.67 4.90 2.85 8 2006 [30] 
"Ivanovski N" 12748350 53 4.82 2.24 4.37 2.16 9 2003 [31] 
"Spiroski M" OR "Spirovski M" 20331842 21 5.25 2.90 4.81 1.81 26 2010 [32] 
"Tofovic S" 18981180 71 11.83 3.86 6.76 3.07 6 2008 [33] 
"Rosoklija G" 19606083 208 41.60 3.87 6.56 10.75 7 2009 [34] 
"Pop-Jordanova N" OR "Pop Jordanova N" 18816642 16 2.67 1.85 3.03 1.44 7 2008 [35] 
 
 
 The main parameter Relative Citation Ratio 
(RCR) of the most influenced individual papers 
deposited in PubMed have shown the biggest value 
for Efremov D with 35.19 or 35 times more citations 
than expected in his field [20]. On the second place is 
the paper of Spasovski G with RCR of 13.48 [19], and 
on the third place is the paper of Rosoklija G with 
RCR of 10.75 [34]. Five of the top twenty Macedonian 
biomedical scientists have RCR below 2.0 (Bosevski 
M [24], Spiroski M OR Spirovski M [32], Popov Z [29], 
Pop-Jordanova N OR Pop Jordanova N [35], and 
Grcevska L OR Grchevska L [28]) and the rest of 
them are in the range of 2.0 and 10.0 (Table 2). 
 The number of authors of the most influenced 
individual papers deposited in PubMed by top twenty 
Macedonian biomedical scientists varies from 2 
authors to 860 authors per published paper. The 
biggest number of authors (860) was noticed in the 
paper of Efremov D [20] following the paper from 
Bosevski M [24] with 125 authors. Four papers [17, 
19, 23, 32] have 24, 25 or 26 authors, respectively. 
The rest of the papers have less than 12 authors 
(Table 2). 
 
 
Discussion 
  
In this paper, Relative Citation Ratio (RCR) of 
top twenty Macedonian biomedical scientists in 
PubMed with a new metric that uses citation rates to 
measure influence at the article level was presented. 
The lowest RCR was calculated for Grcevska L OR 
Grchevska L. The biggest number of top twenty 
Macedonian biomedical scientists have Relative 
citation ratio lower than one, which means lower 
citation than calculated citation in PubMed for the 
given subject. Only four Macedonian biomedical 
scientists have bigger RCR in comparison with those 
in PubMed. The most prominent RCR of 2.29 has 
Rosoklija G, a member of Macedonian Academy of 
Science and Arts, and affiliated at Department of 
Psychiatry, Columbia University, New York, New 
York, USA. Relative Citation Ratio (RCR) of the most 
influenced individual papers deposited in PubMed has 
shown the biggest value for the paper of Efremov D 
[20]. This paper has the biggest number of authors 
(860).  
  Analysis of the impact of scientists is a very 
sensitive issue. First paper about the current 
individual scientific impact of the academic staff 
employed at the Institutes, Faculty of Medicine, Ss 
Cyril and Methodius University of Skopje, Republic of 
Macedonia and to the creation of a list of Top Ten 
Scientists was published in 2009 [36]. The paper was 
not accepted as an objective measure of the current 
achievements of the scientists but rather as an “attack 
on the privacy” of the scientists.  
Four years later semantically analysis of 
medical abstracts from the Republic of Macedonia 
indexed in the PubMed database with GoPubMed was 
published [37]. A total number of 1469 abstracts were 
identified for analysis. Macedonian medical scientists 
published papers in a total of 400 different journals 
which have been indexed in PubMed database. Top 
twenty Macedonian authors published 72.4% of the 
total number of abstracts indexed in PubMed.  
 The most influenced individual papers 
deposited in PubMed obtained with the iCite from the 
top twenty Macedonian biomedical scientists have 
shown similar results with the previously published 
results [14, 15, 36, 37]. Interestingly, the paper with 
the biggest RECR [20] is double-blind, placebo-
controlled trial, which contains randomly assigned 
15,526 patients with a recent acute coronary 
syndrome to receive twice-daily doses of either 2.5 
mg or 5 mg of rivaroxaban or placebo for a mean of 
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13 months and up to 31 months. In this paper, the 
primary efficacy endpoint was a composite of death 
from cardiovascular causes, myocardial infarction, or 
stroke. As an authors included in this paper were 
mentioned 860 scientists connected with the cohort of 
15,526 randomly selected patients. The second paper 
[24] with the 125 authors was the clinical presentation 
of venous thromboembolism (VTE), namely 
pulmonary embolism (PE) or deep venous thrombosis 
(DVT), and the outcome at 3 months (death, recurrent 
VTE or bleeding) and comparison between 2,984 
COPD patients and 25,936 non-COPD patients 
included in the RIETE (Registro Informatizado de la 
Enfermedad TromboEmbólica) registry. From these 
two examples, we can suggest that multicentre 
studies have bigger RCR than other scientific papers. 
 Another characteristic of the most influenced 
individual papers deposited in PubMed by the top 
twenty Macedonian biomedical scientists is their 
connection with National Institutes of Health (NIH) 
grants. Most of the scientists with the highest RCR 
received or are included in the grants and scientific 
groups connected with NIH [20, 22, 33, 34]. 
 Article-level metrics (ALMs) provide a wide 
range of metrics about the uptake of an individual 
journal article by the scientific community after 
publication. They include citations, usage statistics, 
discussions in online comments and social media, 
social bookmarking, and recommendations. There are 
numerous article-level metrics and each has its own 
advantages and problems.  
Citation counts are an excellent measure of 
influence and impact but are very slow to collect. 
Download statistics are rapid to collect but may be 
misleading. Comments can provide valuable and 
immediate feedback, but are currently sparse and 
require a change in the research reward culture to 
become more widespread and to improve quality. The 
paper on article-level metrics was published as an 
Information Standards Quarterly [38] in 2013.  
In the recent article it was stated that 
Macedonian scholarly publishers have to work on 
implementing of article level metrics in their e-journals. 
It is the way to increase their visibility and impact in 
the world of science [39]. 
Several limitations are connected with this 
study. The most vulnerable are the selection of top 
twenty Macedonian biomedical scientists. In spite of 
the clear definition of the total number of deposited 
abstracts in PubMed, identification of the authors by 
GoPubMed is not ideal. Many authors have more than 
one author identification in the PubMed and they are 
listed several times in the Author list which 
complicates the calculation of the total number of 
deposited abstracts. Some of the authors are not pure 
biomedical scientists but are included in the PubMed 
with the respective number of abstracts. Several 
biomedical scientists born in the Republic of 
Macedonia started to work at home and now are 
working abroad. Some of them are actual members of 
the Macedonian Academy of Arts and Sciences. All 
above-mentioned factors are corrected in the 
selection process of top twenty Macedonian 
biomedical scientists. Thus, it is necessary to accept 
the mentioned list as an example of new metric that 
uses citation rates to measure influence at the article 
level, rather than qualification of the best Macedonian 
biomedical scientists.  
   In conclusion, I can say that a new metric that 
uses citation rates to measure influence at the article 
level in the form of Relative Citation Ratio (RCR) can 
be used to analyze top twenty Macedonian biomedical 
scientists in PubMed. We can use the most influenced 
individual papers deposited in PubMed  obtained with 
the iCite as a personal achievement of the certain 
scientist, but in the same time as a comparison 
between scientists as a group (research group, project 
group, institution, country, defined list of scientists and 
similar). 
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